STOCK TITAN

[6-K] Haleon plc American Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary

Haleon plc (LSE/NYSE:HLN) announced PDMR notifications describing grants of share awards under its Share Value Plan and Performance Share Plan. The Performance Share Plan (Interim) awards vest in March 2028 subject to continued employment and performance conditions covering the period ending 31 December 2027; the relevant performance targets were disclosed in Haleon’s 2024 Annual Report and Form 20-F. The Share Value Plan (Buyout) awards are subject to continued employment. All awards were made in line with Haleon’s Directors' Remuneration Policy and are subject to malus and clawback provisions.

The filing discloses aggregate award volumes including items of 192,571 and 405,911 (shares/ADS) and notes that some volumes are Nil where applicable. No financial amounts, prices, or additional compensation details are provided in this report.

Haleon plc (LSE/NYSE:HLN) ha comunicato notifiche PDMR relative a concessioni di azioni nell'ambito del suo Share Value Plan e del Performance Share Plan. Le assegnazioni del Performance Share Plan (Interim) maturano a marzo 2028, soggette a permanenza in servizio e a condizioni di performance riferite al periodo terminante il 31 dicembre 2027; gli obiettivi di performance pertinenti sono stati resi noti nel Bilancio annuale 2024 di Haleon e nel modulo 20‑F. Le assegnazioni del Share Value Plan (Buyout) sono subordinate alla continuazione dell'impiego. Tutte le assegnazioni sono state effettuate in conformità alla Remunerazione dei Direttori e sono soggette a clausole di malus e clawback.

Il documento riporta i volumi aggregati delle assegnazioni, inclusi importi di 192.571 e 405.911 (azioni/ADS), e indica che alcuni volumi possono risultare Nil ove applicabile. In questo rapporto non sono riportati importi finanziari, prezzi o dettagli aggiuntivi sulla compensazione.

Haleon plc (LSE/NYSE:HLN) anunció notificaciones PDMR que describen concesiones de acciones dentro de su Share Value Plan y Performance Share Plan. Las adjudicaciones del Performance Share Plan (Interim) vencen en marzo de 2028, sujetas a la continuidad en el empleo y a condiciones de rendimiento correspondientes al periodo que finaliza el 31 de diciembre de 2027; los objetivos de rendimiento relevantes se divulgaron en el Informe Anual 2024 de Haleon y en el Formulario 20‑F. Las adjudicaciones del Share Value Plan (Buyout) están sujetas a la continuidad en el empleo. Todas las concesiones se realizaron de acuerdo con la Política de Remuneración de los Directores de Haleon y están sujetas a disposiciones de malus y clawback.

La presentación divulga los volúmenes agregados de las adjudicaciones, incluidos elementos de 192.571 y 405.911 (acciones/ADS), y señala que algunos volúmenes son Nil cuando procede. En este informe no se facilitan importes financieros, precios ni detalles adicionales sobre la compensación.

Haleon plc (LSE/NYSE:HLN)는 Share Value Plan 및 Performance Share Plan에 따른 주식 수여에 관한 PDMR 통지를 발표했습니다. Performance Share Plan(Interim) 수여분은 2028년 3월에 베스팅되며, 근속과 2027년 12월 31일로 종료되는 기간을 대상으로 하는 성과조건을 충족해야 합니다; 관련 성과 목표는 Haleon의 2024 연차보고서 및 Form 20‑F에 공개되어 있습니다. Share Value Plan(Buyout) 수여분은 계속 고용 상태가 조건입니다. 모든 수여는 Haleon의 이사회 보수정책에 따라 이루어졌으며 malus 및 clawback 규정의 적용을 받습니다.

해당 제출자료는 192,571 및 405,911(주/ADS) 등 항목을 포함한 총 수여 물량을 공시하며, 해당되는 경우 일부 물량은 Nil로 표시될 수 있음을 명시합니다. 본 보고서에는 금전 액수, 가격 또는 추가 보수 세부사항은 포함되어 있지 않습니다.

Haleon plc (LSE/NYSE:HLN) a annoncé des notifications PDMR décrivant des attributions d'actions dans le cadre de son Share Value Plan et de son Performance Share Plan. Les attributions du Performance Share Plan (Interim) acquièrent des droits en mars 2028, sous réserve de la poursuite de l'emploi et de conditions de performance couvrant la période se terminant le 31 décembre 2027 ; les objectifs de performance pertinents ont été divulgués dans le rapport annuel 2024 de Haleon et dans le formulaire 20‑F. Les attributions du Share Value Plan (Buyout) sont soumises à la continuité de l'emploi. Toutes les attributions ont été effectuées conformément à la politique de rémunération des administrateurs de Haleon et sont soumises à des dispositions de malus et de clawback.

Le dépôt divulgue les volumes agrégés des attributions, incluant des éléments de 192 571 et 405 911 (actions/ADS), et précise que certains volumes sont Nil le cas échéant. Aucun montant financier, prix ou détail supplémentaire de rémunération n'est fourni dans ce rapport.

Haleon plc (LSE/NYSE:HLN) hat PDMR‑Meldungen veröffentlicht, die Gewährungen von Aktienzuwendungen im Rahmen des Share Value Plan und des Performance Share Plan beschreiben. Die Zuwendungen des Performance Share Plan (Interim) laufen im März 2028 zur Vesting aus, vorbehaltlich fortgesetzter Anstellung und Performance‑Bedingungen für den bis zum 31. Dezember 2027 laufenden Zeitraum; die relevanten Leistungsziele wurden im Haleon Jahresbericht 2024 und im Formular 20‑F offengelegt. Die Zuwendungen des Share Value Plan (Buyout) sind an die Fortsetzung der Anstellung gebunden. Alle Zuwendungen erfolgten im Einklang mit der Vergütungspolitik für Direktoren von Haleon und unterliegen Malus‑ und Clawback‑Bestimmungen.

Die Einreichung gibt aggregierte Zuwendungsvolumina an, einschließlich Beträgen von 192.571 und 405.911 (Aktien/ADS), und weist darauf hin, dass einige Volumina, wo zutreffend, Nil sein können. In diesem Bericht werden keine finanziellen Beträge, Preise oder weiteren Vergütungsdetails angegeben.

Positive
  • Awards align with the company's Directors' Remuneration Policy
  • Performance Share Plan awards include explicit performance and service conditions
  • Awards are subject to malus and clawback provisions
  • Performance period and vesting timetable are clearly stated (performance period ends 31 December 2027; vesting in March 2028)
Negative
  • None.

Insights

TL;DR: Routine director/PDMR award disclosures confirm governance controls with performance vesting, malus and clawback protections.

The disclosure is a standard Market Abuse Regulation notification that records grants to persons discharging managerial responsibilities. It reiterates that Performance Share Plan awards carry performance and service conditions through 31 December 2027 with vesting in March 2028 and references previously disclosed targets in the 2024 Annual Report and Form 20-F. The mention of malus and clawback provisions indicates governance mechanisms to adjust awards for misconduct or restatements, consistent with the company’s stated Remuneration Policy. The filing lacks pricing, grant date fair value, or individual award sizes, limiting assessment of dilution or compensation magnitude.

TL;DR: Disclosure outlines award types and vesting framework but omits monetary or per-recipient details needed for pay analysis.

The report differentiates between Performance Share Plan (Interim) awards, which are performance- and service-conditioned, and Share Value Plan (Buyout) awards, which are service-conditioned. Aggregate volumes shown include figures of 192,571 and 405,911, suggesting grant quantities were recorded, but the filing does not present prices, grant-date valuations, or recipient-level allocations. For pay benchmarking or assessing incentive alignment, readers must consult the 2024 Annual Report/Form 20-F for the specific performance targets and any earlier disclosures on award quantum and valuation.

Haleon plc (LSE/NYSE:HLN) ha comunicato notifiche PDMR relative a concessioni di azioni nell'ambito del suo Share Value Plan e del Performance Share Plan. Le assegnazioni del Performance Share Plan (Interim) maturano a marzo 2028, soggette a permanenza in servizio e a condizioni di performance riferite al periodo terminante il 31 dicembre 2027; gli obiettivi di performance pertinenti sono stati resi noti nel Bilancio annuale 2024 di Haleon e nel modulo 20‑F. Le assegnazioni del Share Value Plan (Buyout) sono subordinate alla continuazione dell'impiego. Tutte le assegnazioni sono state effettuate in conformità alla Remunerazione dei Direttori e sono soggette a clausole di malus e clawback.

Il documento riporta i volumi aggregati delle assegnazioni, inclusi importi di 192.571 e 405.911 (azioni/ADS), e indica che alcuni volumi possono risultare Nil ove applicabile. In questo rapporto non sono riportati importi finanziari, prezzi o dettagli aggiuntivi sulla compensazione.

Haleon plc (LSE/NYSE:HLN) anunció notificaciones PDMR que describen concesiones de acciones dentro de su Share Value Plan y Performance Share Plan. Las adjudicaciones del Performance Share Plan (Interim) vencen en marzo de 2028, sujetas a la continuidad en el empleo y a condiciones de rendimiento correspondientes al periodo que finaliza el 31 de diciembre de 2027; los objetivos de rendimiento relevantes se divulgaron en el Informe Anual 2024 de Haleon y en el Formulario 20‑F. Las adjudicaciones del Share Value Plan (Buyout) están sujetas a la continuidad en el empleo. Todas las concesiones se realizaron de acuerdo con la Política de Remuneración de los Directores de Haleon y están sujetas a disposiciones de malus y clawback.

La presentación divulga los volúmenes agregados de las adjudicaciones, incluidos elementos de 192.571 y 405.911 (acciones/ADS), y señala que algunos volúmenes son Nil cuando procede. En este informe no se facilitan importes financieros, precios ni detalles adicionales sobre la compensación.

Haleon plc (LSE/NYSE:HLN)는 Share Value Plan 및 Performance Share Plan에 따른 주식 수여에 관한 PDMR 통지를 발표했습니다. Performance Share Plan(Interim) 수여분은 2028년 3월에 베스팅되며, 근속과 2027년 12월 31일로 종료되는 기간을 대상으로 하는 성과조건을 충족해야 합니다; 관련 성과 목표는 Haleon의 2024 연차보고서 및 Form 20‑F에 공개되어 있습니다. Share Value Plan(Buyout) 수여분은 계속 고용 상태가 조건입니다. 모든 수여는 Haleon의 이사회 보수정책에 따라 이루어졌으며 malus 및 clawback 규정의 적용을 받습니다.

해당 제출자료는 192,571 및 405,911(주/ADS) 등 항목을 포함한 총 수여 물량을 공시하며, 해당되는 경우 일부 물량은 Nil로 표시될 수 있음을 명시합니다. 본 보고서에는 금전 액수, 가격 또는 추가 보수 세부사항은 포함되어 있지 않습니다.

Haleon plc (LSE/NYSE:HLN) a annoncé des notifications PDMR décrivant des attributions d'actions dans le cadre de son Share Value Plan et de son Performance Share Plan. Les attributions du Performance Share Plan (Interim) acquièrent des droits en mars 2028, sous réserve de la poursuite de l'emploi et de conditions de performance couvrant la période se terminant le 31 décembre 2027 ; les objectifs de performance pertinents ont été divulgués dans le rapport annuel 2024 de Haleon et dans le formulaire 20‑F. Les attributions du Share Value Plan (Buyout) sont soumises à la continuité de l'emploi. Toutes les attributions ont été effectuées conformément à la politique de rémunération des administrateurs de Haleon et sont soumises à des dispositions de malus et de clawback.

Le dépôt divulgue les volumes agrégés des attributions, incluant des éléments de 192 571 et 405 911 (actions/ADS), et précise que certains volumes sont Nil le cas échéant. Aucun montant financier, prix ou détail supplémentaire de rémunération n'est fourni dans ce rapport.

Haleon plc (LSE/NYSE:HLN) hat PDMR‑Meldungen veröffentlicht, die Gewährungen von Aktienzuwendungen im Rahmen des Share Value Plan und des Performance Share Plan beschreiben. Die Zuwendungen des Performance Share Plan (Interim) laufen im März 2028 zur Vesting aus, vorbehaltlich fortgesetzter Anstellung und Performance‑Bedingungen für den bis zum 31. Dezember 2027 laufenden Zeitraum; die relevanten Leistungsziele wurden im Haleon Jahresbericht 2024 und im Formular 20‑F offengelegt. Die Zuwendungen des Share Value Plan (Buyout) sind an die Fortsetzung der Anstellung gebunden. Alle Zuwendungen erfolgten im Einklang mit der Vergütungspolitik für Direktoren von Haleon und unterliegen Malus‑ und Clawback‑Bestimmungen.

Die Einreichung gibt aggregierte Zuwendungsvolumina an, einschließlich Beträgen von 192.571 und 405.911 (Aktien/ADS), und weist darauf hin, dass einige Volumina, wo zutreffend, Nil sein können. In diesem Bericht werden keine finanziellen Beträge, Preise oder weiteren Vergütungsdetails angegeben.

UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of September 2025
 
Commission File Number: 001-41411
 
Haleon plc
(Translation of registrant’s name into English)
 
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address of principal executive offices)
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
 
 
Form 20-F
 
Form 40-F
 
 
 
EXHIBIT INDEX
 
Exhibit Number
Description
99.1
05 September 2025 - “Director/PDMR Shareholding”
 
 
 
 
99.1
 
 
 Haleon plcDirector/PDMR Shareholding 
 
5 September 2025: Haleon plc (the "Company" or "Haleon") (LSE/NYSE:HLN) today announces notification and public disclosure in accordance with the requirements of The UK Market Abuse Regulation of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs").
 
This notification sets out the details of the grant of Haleon share awards over Ordinary Shares and American Depositary Shares (ADS) made to PDMRs under the Haleon Share Value Plan and Performance Share Plan.
 
 
The Performance Share Plan (Interim) awards are subject to continued employment and performance conditions over the performance period ending on 31 December 2027 (vesting in March 2028). Performance targets were disclosed in the Annual Report and Form 20-F 2024.
 
 
The Share Value Plan (Buyout) awards are subject to continued employment.
 
All awards were made in line with the principles of Haleon's Directors' Remuneration Policy and are subject to malus and clawback provisions.
 
 
 
Details of the person discharging managerial responsibilities / person closely associated  
 
a)  
 
Name  
 
Carl Haney
 
 
Reason for the notification  
 
a)  
 
Position/status  
 
Chief R&D Officer
b)  
 
Initial notification /Amendment 
Initial Notification 
 
 
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  
a)  
 
Name  
 
Haleon plc 
b)  
 
LEI  
 
549300PSB3WWEODCUP19 
 
 
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  
a)  
 
Description of the financial instrument, type of instrument  
 
Identification code  
Ordinary Shares of £0.01 each
 
GB00BMX86B70   
 
b)  
 
Nature of the transaction  
 
(i)           Grant of a conditional award under the Haleon plc Performance Share Plan (Interim)
 
(ii)          Grant of a conditional award under the Haleon plc Share Value Plan (Buyout)
 
c)  
 
Price(s) and volume(s)  
 
Price(s)
 
Volume(s) 
(i)
Nil
641,096
 
(ii)
Nil
192,571
 
d)  
 
Aggregated information  
 
- Aggregated volume 
 
- Price 
 
 
833,667
 
Nil
 
e)  
 
Date of the transaction  
 
4 September 2025
f)  
 
Place of the transaction  
 
Outside a trading venue
 
 
 
 
 
Details of the person discharging managerial responsibilities / person closely associated  
 
a)  
 
Name  
 
Nathalie Gerschtein
 
 
Reason for the notification  
 
a)  
 
Position/status  
 
President North America
b)  
 
Initial notification /Amendment 
Initial Notification 
 
 
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  
a)  
 
Name  
 
Haleon plc 
b)  
 
LEI  
 
549300PSB3WWEODCUP19 
 
 
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  
a)  
 
Description of the financial instrument, type of instrument  
 
Identification code  
Haleon plc American Depositary Shares (ADS)
   
US4055521003 
 
b)  
 
Nature of the transaction  
 
(i)           Grant of a conditional award under the Haleon plc Performance Share Plan (Interim)
 
(ii)          Grant of a conditional award under the Haleon plc Share Value Plan (Buyout)
 
c)  
 
Price(s) and volume(s)  
 
Price(s)
 
Volume(s) 
(i)
Nil
 
244,400
(ii)
Nil
 
405,911
d)  
 
Aggregated information  
 
- Aggregated volume 
 
- Price 
 
 
 
650,311
 
Nil
e)  
 
Date of the transaction  
 
4 September 2025
f)  
 
Place of the transaction  
 
Outside a trading venue
 
 
Amanda Mellor
Company Secretary
 
About Haleon
Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.
 
For more information, please visit www.haleon.com
 
 
SIGNATURE
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
HALEON PLC
(Registrant)
 
Date: September 05, 2025
By:
/s/ Amanda Mellor
 
 
Name:
Amanda Mellor
 
 
Title:
Company Secretary

FAQ

What did Haleon (HLN) disclose in this Form 6-K about director awards?

The company disclosed grants of share awards to PDMRs under the Share Value Plan and Performance Share Plan, including aggregate volumes of 192,571 and 405,911 where shown.

When do the Performance Share Plan awards vest for Haleon?

The Performance Share Plan (Interim) awards vest in March 2028 and are subject to performance and continued employment through 31 December 2027.

Are the awarded shares subject to clawback at Haleon?

Yes. The filing states all awards are subject to malus and clawback provisions.

Where can I find the specific performance targets referenced in the filing?

The filing states performance targets were disclosed in Haleon’s 2024 Annual Report and Form 20-F.

Does the Form 6-K provide grant prices or monetary values for the awards?

No. The report does not include prices, grant-date valuations, or recipient-level compensation amounts.
Haleon

NYSE:HLN

HLN Rankings

HLN Latest News

HLN Latest SEC Filings

HLN Stock Data

44.04B
4.48B
0.02%
12.82%
0.39%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United Kingdom
Weybridge